Last week prominent medical cannabis campaigner Charlotte Caldwell launched the #iambilly campaign. Grow Pharma are delighted to be a key partner of the campaign with Patient Access Lead Alex Fraser taking a role on its Policy Advisory Board.
Grow Pharma has achieved another milestone in the supply of cannabis-based medicinal products (CBMPs) to patients by trialling an extraction of a CBMP in a UK licensed facility. Read the full press release below:https://pressat.co.uk/releases/uk-medicinal-cannabis-company-grow-pharma-to-produce-cannabis-based-medicinal-products-for-patients-facing-possible-disruption-in-supply-36899a3664bf74e746ec6c8b9098c02c/
Medical cannabis biopharma leader Grow launches GBP 6 million Series C fundraise to scale-up existing UK operations and accelerate expansion across Europe. Grow seeks to accelerate towards its goal of being the world’s leading supplier … Read More
Manufacturers use several different ways of naming their products and for communicating its content. Some use a percentage for the concentration, where 5% CBD actually doesn’t mean 5mg/ml but 50mg/ml because one always works back … Read More